Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative neurological disorder that leads to muscle ...
A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...
A population-based study of nearly 4,000 ALS patients in Italy shows that the widely used pre-diagnostic ALSFRS-R slope ...
By facilitating research on amyotrophic lateral sclerosis and frontotemporal dementia, Yentli Soto Albrecht hopes to change ...
Overview: Cerevance's proprietary NETSseq platform can identify novel targets from specific neuronal and glial cell types from the human brain, as illustrated by KCNK13. Cerevance's compound, CVN293 ...
In Canada, between 3,000 and 4,000 people are living with amyotrophic lateral sclerosis (ALS), a disease that remains incurable. ALS is best known for the degeneration of motor neurons, which are ...
Hosted on MSN
Amyotrophic lateral sclerosis and myasthenia gravis are two separate neurological disorders: Minister
NEW DELHI: The Centre does not cover Amyotrophic Lateral Sclerosis (ALS) and Myasthenia Gravis, two distinct neurological disorders, as rare diseases under the National Policy for Rare Diseases (NPRD) ...
Amyotrophic lateral sclerosis (ALS) is characterised by progressive degeneration of upper and lower motor neurons, leading to muscle weakness, spasticity and respiratory failure. Pathogenic mechanisms ...
Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi ...
Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 accompanies ...
The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results